|
Volumn 131, Issue 7, 2013, Pages 967-969
|
Growth of type 1 neovascularization following cessation of anti-vascular endothelial growth factor therapy as a possible explanation for treatment resistance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFLIBERCEPT;
RANIBIZUMAB;
AGED;
CASE REPORT;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
LETTER;
MALE;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RETINA MACULA AGE RELATED DEGENERATION;
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;
SUBRETINAL FLUID;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT RESPONSE;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DRUG RESISTANCE;
FEMALE;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
RECURRENCE;
RETINAL NEOVASCULARIZATION;
SUBRETINAL FLUID;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
WET MACULAR DEGENERATION;
WITHHOLDING TREATMENT;
|
EID: 84880294088
PISSN: 21686165
EISSN: None
Source Type: Journal
DOI: 10.1001/jamaophthalmol.2013.2120 Document Type: Letter |
Times cited : (5)
|
References (5)
|